We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Vwr Corp. (MM) | NASDAQ:VWR | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 33.25 | 33.24 | 33.26 | 0 | 00:00:00 |
From Mar 2020 to Mar 2025
RADNOR, Pennsylvania, Sept. 25, 2017 /PRNewswire/ -- VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, celebrated the opening of its new kitting center in Skalice, Czech Republic. This new facility will support the growing business of Therapak, which VWR acquired in 2016, by expanding its existing footprint in Europe with a state of the art facility and comprehensive kitting services for regional and global customers.
"VWR's Czech Republic facility is strategically located to support customers in the EMEA region for all their clinical and commercial kitting needs," said Ulf Kepper, SVP, Services for VWR. "This location expands our VWRCATALYST offering to support the growing demand for quality services to the industries we support."
The 35,000-square foot facility will be fully operational on October 2, 2017, and is in proximity to major industrial freight carrier hubs, which is ideal for shipping and will allow enhanced service levels compared to VWR's current model.
Therapak, a leading supplier of pre-packaged convenience kits and procedure packs for the clinical trial, pharmaceutical and clinical laboratory industries, has proven to be a valued addition to the VWRCATALYST Clinical and Biorepository Services.
Along with the recent acquisitions of MESM and EPL Archives, VWRCATALYST Clinical and Biorepository Services offers a complete solution to its global regulated research and product development clients in the pharma, biopharma, manufacturing and clinical trial industries. Our focus is to eliminate the process complexities and identify service solutions that help labs and production facilities work better, faster, and smarter. Â
About VWRÂ
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
For more information on VWR please visit www.vwr.com.
Media Contact:
Valerie Collado
Director, Corporate Communications
VWRÂ
484.885.9338
Valerie_collado@vwr.com
Photo - http://mma.prnewswire.com/media/560515/VWR_Czech_Republic_Kitting_Center_Ribbon_Cutting.jpg
Logo -Â http://mma.prnewswire.com/media/95343/vwr_international__llc_logo.jpg
Copyright 2017 PR Newswire
1 Year VWR CORP Chart |
1 Month VWR CORP Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
